All In Biotech

Drug Trial Radar · NCT07686055

Precision Management of Urinary Tract Symptoms in Older Women

Precision Management of Urinary Tract Symptoms in Older Women: A Randomized Trial to Reduce Overtreatment

Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Jul 23, 2026

Primary completion

Feb 1, 2027

Study completion Feb 14, 2027

Sponsor

Lead sponsor
Megan BradleyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
American Association of Obstetricians and Gynecologists Foundation (AAOGF)
First posted
Jul 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This project aims to improve the diagnosis and management of urinary tract symptoms in older women by comparing three common treatment strategies-empiric antibiotics, urinalysis-guided therapy, and culture-directed care-in a randomized trial. By integrating patient-reported outcomes, laboratory data, the study will identify which patients benefit from antibiotics and which can safely avoid them. Findings will inform precision care strategies and promote antibiotic stewardship while improving symptom outcomes and quality of life in this high-risk population.

Conditions

  • Urinary Tract Infection (Diagnosis)

Interventions

  • AntibioticsDrug

    Participants will be provided either nitrofurantoin 100 mg oral twice a day for 5 days, trimethoprim/sulfamethoxazole 875/125 oral twice a day for 3 days, fosfomycin 3g once oral, ciprofloxacin 250 mg oral twice a day for 5 days or cephalexin 500 mg oral twice a day for 5 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Success at 14 DaysTime frame: 14 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UPMC-Magee Womens Hospital

    Pittsburgh, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.